Skip to main content
Enter your The Contraceptive Pipeline Database username.
Enter the password that accompanies your username.
EVE-112 Vaginal Ring
Etonogestrel (ENG) + ethinylestradiol (EE) vaginal ring; EVE112
A vaginal ring expected to be a bioequivalent to NuvaRing. The new vaginal delivery system has not been disclosed and is being considered for a patent application.
May 30, 2018
Active Pharmaceutical Ingredient (API):
Potential Multi-Purpose Technology (MPT):
Etonogestrel: 5mg, ethinyl estradiol: 0.85mg
Gedeon Richter Plc.
Phase-II clinical trials are taking place in Germany and pre-clinical trials are underway in USA.
Evestra, Inc. website
Phase II clinical trial
Download Product Report